Paid Clinical Trials Tennessee
Discover 1,838 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Von Willebrand FactorVon Willebrand Factor in Pregnancy (VIP) Study
Sponsor:
University of Washington
Location:
Code:
NCT04146376
Conditions
Von Willebrand Diseases
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Use of a postpartum diary and additional blood draws
VWF replacement therapy with Wilate
Tranexamic acid
Use of a postpartum diary and additional blood draws.
Proton TherapyEvaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
Sponsor:
St. Jude Children's Research Hospital
Location:
Code:
NCT04065776
Conditions
Glioma
Pilocytic Astrocytoma
Pilomyxoid Astrocytoma
Pleomorphic Xanthoastrocytoma
Ganglioglioma
Eligibility Criteria
Sex: All
Age: 6 - 21
Healthy Volunteers: Not accepted
Interventions
Hippocampal-avoidance proton therapy
RavulizumabStudy of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
Sponsor:
Alexion Pharmaceuticals, Inc.
Location:
Code:
NCT06291376
Conditions
Immunoglobulin A Nephropathy
IgAN
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ravulizumab
Placebo
CLN-619 & PembrolizumabA Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
Sponsor:
Cullinan Therapeutics Inc.
Location:
Code:
NCT05117476
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CLN-619
Pembrolizumab
Observational StudyProduct Surveillance Registry
Sponsor:
Medtronic
Location:
Code:
NCT01524276
Conditions
Cardiac Rhythm Disorders
Urological Disorders
Neurological Disorders
Cardiovascular Disorders
Digestive Disorders
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Observational StudyProspective Clinical Assessment Study in Children with Hypochondroplasia
Sponsor:
QED Therapeutics, Inc.
Location:
Code:
NCT06410976
Conditions
Hypochondroplasia
Eligibility Criteria
Sex: All
Age: 30 - 16
Healthy Volunteers: Not accepted
Proton vs. PhotonComparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
Sponsor:
NRG Oncology
Location:
Code:
NCT03801876
Conditions
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
Clinical Stage II Esophageal Adenocarcinoma AJCC v8
Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Esophagectomy
Intensity-Modulated Radiation Therapy
Paclitaxel
Proton Beam Radiation Therapy
TAK-279A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Sponsor:
Takeda
Location:
Code:
NCT06550076
Conditions
Plaque Psoriasis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TAK-279
PM359A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )
Sponsor:
Prime Medicine, Inc.
Location:
Code:
NCT06559176
Conditions
Chronic Granulomatous Disease
Granulomatous Disease, Chronic
Eligibility Criteria
Sex: All
Age: 6+
Healthy Volunteers: Not accepted
Interventions
PM359
SelgantolimodStudy of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Location:
Code:
NCT05551273
Conditions
Hepatitis B
HIV Infections
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Selgantolimod
Placebo